Quality of life for patients on oncology treatments in the Kingdom of Saudi Arabia: a systematic review
Background Cancer cases in the Kingdom of Saudi Arabia (KSA) have tripled in recent years. Quality of Life (QoL) measurements are crucial for healthcare professionals because they reveal important information about how patients respond to drugs and their general health. This study aimed to collect a...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Journal of Pharmaceutical Policy and Practice |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/20523211.2024.2449036 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841543117000409088 |
---|---|
author | Abdullah U. Althemery Rawan Alzahrani Nura Alajlan Abdullah M. Alrajhi |
author_facet | Abdullah U. Althemery Rawan Alzahrani Nura Alajlan Abdullah M. Alrajhi |
author_sort | Abdullah U. Althemery |
collection | DOAJ |
description | Background Cancer cases in the Kingdom of Saudi Arabia (KSA) have tripled in recent years. Quality of Life (QoL) measurements are crucial for healthcare professionals because they reveal important information about how patients respond to drugs and their general health. This study aimed to collect and summarise articles exploring the QoL of patients undergoing oncology treatments in KSA.Methods This systematic review captured articles on the Quality of Life of patients undergoing oncology treatments living in the KSA from 2000–2023. A query was established by adapting (PICOS) guidelines for systematic research. A systematic review accelerator (SRA) was used to organise the search and enable multiple reviewers to conduct and validate the process.Results Twelve articles met the inclusion criteria. Riyadh and Jeddah contributed to all publications. A total of 2,430 patients with cancer were surveyed; 1,377 patients were female (56.67%) with an average age of 51.23 years. Six articles mentioned pharmacological interventions, whereas the remaining articles did not mention which pharmacology had been utilised.Conclusion This systematic review highlights the recent attention given to the patient’s reported outcomes of cancer patients. Further research on rare cancer types is required, particularly for generic instruments. |
format | Article |
id | doaj-art-aa94553a2e224d058c6a8784539dabff |
institution | Kabale University |
issn | 2052-3211 |
language | English |
publishDate | 2025-12-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Journal of Pharmaceutical Policy and Practice |
spelling | doaj-art-aa94553a2e224d058c6a8784539dabff2025-01-13T15:41:54ZengTaylor & Francis GroupJournal of Pharmaceutical Policy and Practice2052-32112025-12-0118110.1080/20523211.2024.2449036Quality of life for patients on oncology treatments in the Kingdom of Saudi Arabia: a systematic reviewAbdullah U. Althemery0Rawan Alzahrani1Nura Alajlan2Abdullah M. Alrajhi3Department of Clinical Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi ArabiaDepartment of Clinical Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi ArabiaDepartment of Clinical Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi ArabiaClinical Pharmacy Department, King Fahad Medical City, Riyadh, Saudi ArabiaBackground Cancer cases in the Kingdom of Saudi Arabia (KSA) have tripled in recent years. Quality of Life (QoL) measurements are crucial for healthcare professionals because they reveal important information about how patients respond to drugs and their general health. This study aimed to collect and summarise articles exploring the QoL of patients undergoing oncology treatments in KSA.Methods This systematic review captured articles on the Quality of Life of patients undergoing oncology treatments living in the KSA from 2000–2023. A query was established by adapting (PICOS) guidelines for systematic research. A systematic review accelerator (SRA) was used to organise the search and enable multiple reviewers to conduct and validate the process.Results Twelve articles met the inclusion criteria. Riyadh and Jeddah contributed to all publications. A total of 2,430 patients with cancer were surveyed; 1,377 patients were female (56.67%) with an average age of 51.23 years. Six articles mentioned pharmacological interventions, whereas the remaining articles did not mention which pharmacology had been utilised.Conclusion This systematic review highlights the recent attention given to the patient’s reported outcomes of cancer patients. Further research on rare cancer types is required, particularly for generic instruments.https://www.tandfonline.com/doi/10.1080/20523211.2024.2449036Cancerquality of lifeSaudi Arabiabreast cancercolorectal cancer |
spellingShingle | Abdullah U. Althemery Rawan Alzahrani Nura Alajlan Abdullah M. Alrajhi Quality of life for patients on oncology treatments in the Kingdom of Saudi Arabia: a systematic review Journal of Pharmaceutical Policy and Practice Cancer quality of life Saudi Arabia breast cancer colorectal cancer |
title | Quality of life for patients on oncology treatments in the Kingdom of Saudi Arabia: a systematic review |
title_full | Quality of life for patients on oncology treatments in the Kingdom of Saudi Arabia: a systematic review |
title_fullStr | Quality of life for patients on oncology treatments in the Kingdom of Saudi Arabia: a systematic review |
title_full_unstemmed | Quality of life for patients on oncology treatments in the Kingdom of Saudi Arabia: a systematic review |
title_short | Quality of life for patients on oncology treatments in the Kingdom of Saudi Arabia: a systematic review |
title_sort | quality of life for patients on oncology treatments in the kingdom of saudi arabia a systematic review |
topic | Cancer quality of life Saudi Arabia breast cancer colorectal cancer |
url | https://www.tandfonline.com/doi/10.1080/20523211.2024.2449036 |
work_keys_str_mv | AT abdullahualthemery qualityoflifeforpatientsononcologytreatmentsinthekingdomofsaudiarabiaasystematicreview AT rawanalzahrani qualityoflifeforpatientsononcologytreatmentsinthekingdomofsaudiarabiaasystematicreview AT nuraalajlan qualityoflifeforpatientsononcologytreatmentsinthekingdomofsaudiarabiaasystematicreview AT abdullahmalrajhi qualityoflifeforpatientsononcologytreatmentsinthekingdomofsaudiarabiaasystematicreview |